"BIRC2" Related Products

Expand
Expand
Expand

Recombinant Human Baculoviral IAP Repeat-containing 2

Cat. No.: BIRC2-2633H
Product Overview: Recombinant human Baculoviral IAP Repeat-containing 2 (amino acids 1-618) was fused to the peptide sequence MATVIDH10SSNG at the N-terminus and expressed inE. coli. cIAP is a member of the inhibitor of apoptosis family of proteins that inhibits proteolytic activity of mature caspases by interaction of the BIR domain with the active caspase.
Description: Baculoviral IAP repeat-containing protein 2 (also known as cIAP1) is a protein that in humans is encoded by the BIRC2 gene. cIAP1 is a member of the Inhibitor of Apoptosis family that inhibit apoptosis by interfering with the activation of caspases.
Source: E. coli.
Form: Liquid.
Formulation: Sterile-filtered in 50 mM NaCl, 20 mM HEPES, 1 mM DTT, 20% glycerol, pH 8.0.
Molar Mass: 72300Da.
Purity: ≥85% by SDS-PAGE.
Storage: ≤ -20oC. Ship: Dry Ice Only.
Gene Name: BIRC2 baculoviral IAP repeat-containing 2 [ Homo sapiens ]
Synonyms:
BIRC2; baculoviral IAP repeat-containing 2; IAP homolog B; IAP-2; NFR2-TRAF signalling complex protein; RING finger protein 48; TNFR2-TRAF-signaling complex protein 2; apoptosis inhibitor 1; baculoviral IAP repeat-containing protein 2; inhibitor of apoptosis protein 2; API1; MIHB; HIAP2; RNF48; cIAP1; Hiap-2; c-IAP1
Gene ID: 329
mRNA Refseq: NM_001166
Protein Refseq: NP_001157
MIM: 601712
UniProt ID: Q13490
Chromosome Location: 11q22
Pathway: Apoptosis; Focal adhesion; NOD-like receptor signaling pathway;Pathways in cancer; Small cell lung cancer; Ubiquitin mediated proteolysis; Apoptosis
Function: metal ion binding; protein N-terminus binding; protein binding; zinc ion binding

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.